Delgocitinib cream linked to low systemic exposure in chronic hand eczema, post hoc analysis shows
From the article
Delgocitinib cream resulted in minimal systemic exposure in adults with moderate-to-severe chronic hand eczema, including under maximal-use conditions, according to a recent post hoc analysis of the 2024 phase 3 DELTA 2 trial. Topical Janus kinase (JAK) inhibitors have expanded the treatment options for chronic inflammatory skin diseases, but systemic absorption remains an important consideration […] The post Delgocitinib cream linked to low systemic exposure in chronic hand eczema, post hoc analysis shows appeared first on Hospital Healthcare Europe .
Continue reading on hospitalhealthcare.comYou might also wanna read
Patient Engagement With Dermatology Visit Notes Remains Low
Medscape·15h ago
Bidirectional phenotype switching between psoriasis and atopic dermatitis characterised
hospitalhealthcare.com·6d ago
Risankizumab outperforms deucravacitinib in moderate psoriasis, interim trial data show
hospitalhealthcare.com·8d ago
Postpartum Hyperpigmentation in a 35-Year-Old Woman: A Clinical Case Presentation
A 35-year-old Black woman of Hispanic ethnicity presented 4 months postpartum with hyperpigmented lines on her lower extremities that develo
ja.ma·17d ago
Demodex Mites: Understanding the Microscopic Organisms Living on Human Skin
Demodex mites are microscopic parasites that naturally live on human skin, primarily in hair follicles and oil glands on the face, neck, and
wb.md·18d ago
Skin inflammation as a sentinel marker for neurodegeneration: Chronic skin disorders may signal dementia risk in older adults
This article discusses the emerging link between chronic inflammatory skin conditions and dementia risk in older adults. It highlights that
pubmed.ncbi.nlm.nih.gov·19d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.